| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2008 | EP1934331A2 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 06/25/2008 | EP1934257A2 Proteasome inhibiting beta lactam compounds |
| 06/25/2008 | EP1934256A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 06/25/2008 | EP1934241A2 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 06/25/2008 | EP1934238A1 Triazole compounds and methods of making and using the same |
| 06/25/2008 | EP1934237A2 Triazole compounds and methods of making and using the same |
| 06/25/2008 | EP1934236A1 Heterobifunctional pan-selectin inhibitors |
| 06/25/2008 | EP1934234A2 Novel amine-borane compounds and uses thereof |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1934231A1 Crystalline sodium salt of cephalosporin antibiotic |
| 06/25/2008 | EP1934229A2 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate |
| 06/25/2008 | EP1934228A2 Raf inhibitor compounds and methods of use thereof |
| 06/25/2008 | EP1934227A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 06/25/2008 | EP1934225A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors |
| 06/25/2008 | EP1934224A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1934222A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 06/25/2008 | EP1934220A1 Inhibitors of the hiv integrase enzyme |
| 06/25/2008 | EP1934219A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 06/25/2008 | EP1934217A1 New compounds ii |
| 06/25/2008 | EP1934216A1 Naphthyridin derivatives |
| 06/25/2008 | EP1934215A1 Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders |
| 06/25/2008 | EP1934214A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 06/25/2008 | EP1934213A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| 06/25/2008 | EP1934212A1 9-azabicyclo [3 . 3 . 1]nonane derivatives as monoamine reuptake inhibitors |
| 06/25/2008 | EP1934210A1 Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | EP1934209A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 06/25/2008 | EP1934208A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 06/25/2008 | EP1934207A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 06/25/2008 | EP1934206A1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 06/25/2008 | EP1934205A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 06/25/2008 | EP1934204A2 Process for preparation of aprepitant |
| 06/25/2008 | EP1934203A2 Alpha2c adrenoreceptor agonists |
| 06/25/2008 | EP1934201A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| 06/25/2008 | EP1934200A1 Tyrosine kinase inhibitors |
| 06/25/2008 | EP1934198A2 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 06/25/2008 | EP1934197A2 Duloxetine hcl polymorphs |
| 06/25/2008 | EP1934196A2 Cytotoxin compounds and methods of isolation |
| 06/25/2008 | EP1934193A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake |
| 06/25/2008 | EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 06/25/2008 | EP1934191A2 Biphenyl derivatives as modulators of voltage gated ion channels |
| 06/25/2008 | EP1934186A2 Renin inhibitors nitroderivatives |
| 06/25/2008 | EP1934185A1 Pyrazole compounds that modulate hsp90 activity |
| 06/25/2008 | EP1934184A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists |
| 06/25/2008 | EP1934182A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 06/25/2008 | EP1934181A2 Kinase inhibitors |
| 06/25/2008 | EP1934177A1 Prolinamide derivatives as sodium channel modulators |
| 06/25/2008 | EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 06/25/2008 | EP1934175A2 Anti-hypercholesterolemic compounds |
| 06/25/2008 | EP1934173A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 06/25/2008 | EP1933945A1 A pharmaceutical composition comprising mahanine useful for the treatment of prostate cancer |
| 06/25/2008 | EP1933862A2 Methods and compositions for oral administration of proteins |
| 06/25/2008 | EP1933860A2 Treatment of optic neuritis |
| 06/25/2008 | EP1933858A1 A medical composition for treating wounds |
| 06/25/2008 | EP1933856A2 Method for treatment or prevention of conditions caused by gram-positive bacteria |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933850A2 Aptamers as agonists |
| 06/25/2008 | EP1933849A2 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 06/25/2008 | EP1933848A2 Phosphoantigen salts of organic bases and methods for their crystallization |
| 06/25/2008 | EP1933847A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 06/25/2008 | EP1933846A2 Compositions comprising phosphatidic acid for treatment of eosinophilia and related disorders |
| 06/25/2008 | EP1933845A2 Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
| 06/25/2008 | EP1933844A1 Combination |
| 06/25/2008 | EP1933843A1 Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives |
| 06/25/2008 | EP1933842A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 06/25/2008 | EP1933841A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 06/25/2008 | EP1933840A2 Use of delmopinol in the treatment of acne |
| 06/25/2008 | EP1933839A1 Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance |
| 06/25/2008 | EP1933837A2 Liquid pharmaceutical compositions of nimodipine |
| 06/25/2008 | EP1933836A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/25/2008 | EP1933835A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 06/25/2008 | EP1933834A1 Benzoxazoles useful in the treatment of inflammation |
| 06/25/2008 | EP1933833A1 Therapy for the treatment of disease |
| 06/25/2008 | EP1933832A2 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1933830A1 Antagonists of sns sodium channels |
| 06/25/2008 | EP1933829A2 Method of combating infection |
| 06/25/2008 | EP1933828A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 06/25/2008 | EP1933827A2 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 06/25/2008 | EP1933826A1 Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture |
| 06/25/2008 | EP1933825A2 Combination methods of saha and targretin for treating cancer |
| 06/25/2008 | EP1933824A2 Hydrazone agents to treat cutaneous lesions |
| 06/25/2008 | EP1933823A1 Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium |
| 06/25/2008 | EP1933822A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 06/25/2008 | EP1933821A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 06/25/2008 | EP1933820A2 Palmarumycin based inhibitors of thioredoxin and methods of using same |
| 06/25/2008 | EP1933819A2 Formulations of aica riboside |
| 06/25/2008 | EP1933818A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 06/25/2008 | EP1933814A2 Nanoparticulate aripiprazole formulations |
| 06/25/2008 | EP1933809A2 Compositions for nasal delivery |
| 06/25/2008 | EP1933805A1 Anti-inflammatory compositions and methods of use |
| 06/25/2008 | EP1933785A2 Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 06/25/2008 | EP1933760A2 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 06/25/2008 | EP1933759A2 Methods of administering rapamycin analogs with anti-inflammatories using medical devices |
| 06/25/2008 | EP1933624A2 Compositions and methods for treatment of airway hypersecretion |
| 06/25/2008 | EP1933622A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 06/25/2008 | EP1877058A4 Use of phycotoxins in veterinary applications |
| 06/25/2008 | EP1861389B1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 06/25/2008 | EP1811994B1 Novel derivatives of porphyrin, particularly chlorins and bacteriochlorins, and uses thereof in photodynamic therapy |
| 06/25/2008 | EP1807398B1 New indole or benzimidazole derivatives |